What are the conditions associated with dyslipidemia pre-pregnancy that put women at greater risk for complications? What is the long term effect of having an obstetrical complication as CVD Risk for the mother and fetus? And, what is the major concern for hypertriglyceridemia in Pg and how do you treat it? Dr. Alan Brown, host, welcomes Dr. Robert A. Wild, who will address these questions and more during this discussion of Lipid Luminations. Dr. Wild is Professor of Reproductive Endocrinology, Obstetrics and Gynecology, Medicine, Family Medicine & Biostatistics and Epidemiology at the University of Oklahoma. And, he is Chief of the Gynecology Service at the VA Medical Center in Oklahoma City, OK.
Managing CVD in Women During Childbearing Years
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What are the conditions associated with dyslipidemia pre-pregnancy that put women at greater risk for complications? What is the long term effect of having an obstetrical complication as CVD Risk for the mother and fetus? And, what is the major concern for hypertriglyceridemia in Pg and how do you treat it? Dr. Alan Brown, host, welcomes Dr. Robert A. Wild, who will address these questions and more during this discussion of Lipid Luminations. Dr. Wild is Professor of Reproductive Endocrinology, Obstetrics and Gynecology, Medicine, Family Medicine & Biostatistics and Epidemiology at the University of Oklahoma. And, he is Chief of the Gynecology Service at the VA Medical Center in Oklahoma City, OK.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Biomarkers of the Storm: Decoding IRI’s Signature
HF Management for Patients with Comorbid Conditions
Navigating Myasthenia Gravis in Adolescents and Young Adults
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?